Lineage Cell Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q2 2019 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Lineage Cell Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2019 to Q2 2022.
  • Lineage Cell Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2022 was $2.38M.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $2.38M Jun 30, 2022 10-Q 2022-08-11
Q3 2019 $6.38M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $6.22M Jun 30, 2019 10-Q 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.